Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers

Journal of Experimental Medicine

Volumn 191, Issue 2, 2000, Pages 335-345

  Daniels, Mark A ^a   Jameson, Stephen C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Calcium; Cytotoxic T lymphocyte; Flow cytometry; MHC peptide tetramers; T cell activation

Indexed keywords

CALCIUM ION; DIMER; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TETRAMER;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL ACTIVATION; CONTROLLED STUDY; FLOW CYTOMETRY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD8; EGG PROTEINS; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MICE; MICE, TRANSGENIC; OVALBUMIN; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL;

EID: 0034677055     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.2.335     Document Type: Article

References (53)

1. Janeway, C.A., Jr. 1992. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10:645-674.
2. Miceli, M.C., and J.R. Parnes. 1993. Role of CD4 and CD8 in T cell activation and differentiation. Adv. Immunol. 53:59-122.
3. Zamoyska, R. 1998. CD4 and CD8: modulators of T-cell receptor recognition of antigen and of immune responses? Curr. Opin. Immunol. 10:82-87.
4. Eichmann, K., N.W. Boyce, R. Schmidt-Ullrich, and J.I. Jonsson. 1989. Distinct functions of CD8(CD4) are utilized at differrent stages of T-lymphocyte differentiation. Immunol. Rev. 109:39-75.
5. Luescher, I.F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, and P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature. 373:353-356.
6. Xu, H., and D.R. Littman. 1993. A kinase-independent function of Lck in potentiating antigen-specific T cell activation. Cell. 74:633-643.
7. Thome, M., V. Germain, J.P. DiSanto, and O. Acuto. 1996. The p56lck SH2 domain mediates recruitment of CD8/ p56lck to the activated T cell receptor/CD3/zeta complex. Eur. J. Immunol. 26:2093-2100.
8. Hamad, A.R., S.M. O'Herrin, M.S. Lebowitz, A. Srikrishnan, J. Bieler, J. Schneck, and D. Pardoll. 1998. Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor. J. Exp. Med. 188:1633-1640.
9. Crawford, F., H. Kozono, J. White, P. Marrack, and J. Kappler. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity. 8:675-682.
10. Boniface, J.J., J.D. Rabinowitz, C. Wulfing, J. Hampl, Z. Reich, J.D. Altman, R.M. Kantor, C. Beeson, H.M. McConnell, and M.M. Davis. 1998. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity. 9:459-466.
11. Madrenas, J., L.A. Chau, J. Smith, J.A. Bluestone, and R.N. Germain. 1997. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC inolectile ligands. J. Exp. Med. 185:219-229.
12. Hampl, J., Y.-H. Chien, and M.M. Davis. 1997. CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity. 7:379-385.
13. Wyer, J.R., B.E. Willcox, G.F. Gao, U.C. Gerth, S.J. Davis, J.I. Bell, P.A. van der Merwe, and B.K. Jakobsen. 1999. T cell receptor and coreceptor CD8 αα bind peptide-MHC independently and with distinct kinetics. Immunity. 10:219-225.
14. O'Rourke, A.M., J. Rogers, and M.F. Mescher. 1990. Activated CD8 binding to class 1 protein mediated by the T-cell receptor results in signalling. Nature. 346:187-189.
15. O'Rourke, A.M., and M.F. Mescher. 1992. Cytotoxic T-lymphocyto activation involves a cascade of signalling and adhesion events. Nature. 358:253-255.
16. Altman, J.D., P.A.H. Moss, P.J.R. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, J.I. Bell, A.J. McMichael, and M.M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:94-96.
17. Murali-Krishna, K., J.D. Altman, M. Suresh, D.J. Sourdive, A.J. Zajac, J.D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of by-stander activation during viral infection. Immunity. 8:177-187.
18. Busch, D.H., I.M. Pilip, S. Vijh, and E.G. Pamer. 1998. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity. 8:353-362.
19. + T cells in primary and secondary influenza pneumonia. Immunity. 8:683-691.
20. Killeen, N., and D.R. Littman. 1993. Helper T-cell development in the absence of CD4-p56lck association. Nature. 364: 729-732.
21. O'Rourke, A.M., B. Ybarrondo, and M.F. Mescher. 1993. CD8 and antigen-specific T cell adhesion cascades. Semin. Immunol. 5:263-270.
22. Madrenas, J., and R.N. Germain. 1996. Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. Semin. Immunol. 8:83-101.
23. Delon, J., C. Gregoire, B. Malissen, S. Darche, F. Lemaitre, P. Kourilsky, J.P. Abastado, and A. Trautmann. 1998. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. Immunity. 9:467-473.
24. Abastado, J.P., Y.C. Lone, A. Casrouge, G. Boulot, and P. Kourilsky. 1995. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J. Exp. Med. 182:439-447.
25. Daniels, M.A., S.L. Schober, K.A. Hogquist, and S.C. Jameson. 1999. Cutting edge: a test of the dominant negative signal model for TCR antagonism. J. Immunol. 162:3761-3764.
26. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76:17-27.
27. Sha, W.C., C.A. Nelson, R.D. Newberry, D.M. Kranz, J.H. Russell, and D.Y. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature. 535:271-274.
28. Udaka, K., K.H. Wiesmuller, S. Kienle, G. Jung, and P. Walden. 1996. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. J. Immunol. 157:670-678.
29. Sarmiento, M., A.L. Glasebrook, and F.W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block F cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665-2762.
30. Ledbetter, J.A., and L.A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63-90.
31. Ledbetter, J.A., R.V. Rouse, H.S. Micklem, and L.A. Herzenberg. 1980. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J. Exp. Med. 152:280-295.
32. Jameson, S.C., F.R. Carbone, and M.J. Bevan. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177:1541-1550.
33. Garcia, K.C., C.A. Scott, A. Brunmark, F.R. Carbone, P.A. Peterson, I.A. Wilson, and L. Teyton. 1996. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature. 384:577-581.
34. Russell, J.H., P. Meleedy-Rey, D.E. McCulley, W.C. Sha, C.A. Nelson, and D.Y. Lob. 1990. Evidence for CD8-independent T cell maturation in transgenic mice. J. Immunol. 144:3318-3325.
35. Cai, Z., and J. Sprent. 1994. Resting and activated T cells display different requirements for CD8 molecules. J. Exp. Med. 179:2005-2015.
36. + T cells in vitro. J. Exp. Med. 183:2247-2257.
37. + T cells. J. Exp. Med. 185:641-651.
38. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Signal extinction and T cell repolarization in T helper cell-antigen-presenting cell conjugates. Eur. J. Immunol. 26: 2012-2016.
39. Alam, S.M., P.J. Travers, J.E. Wung, W. Nasholds, S. Redpath, S.C. Jameson, and N.R.J. Gascoigne. 1996. T-cell receptor affinity and thymocyte positive selection. Nature. 381: 616-620.
40. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1994. Specificity and flexibility in thymic selection. Nature. 369:750-752.
41. McMichael, A.J., and C.A. O'Callaghan. 1998. A new look at T cells. J. Exp. Med. 187:1367-1371.
42. Davis, M.M., J.J. Boniface, Z. Reich, D. Lyons, J. Hampl, B. Arden, and Y. Chien. 1998. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16:523-544.
43. Sykulev, Y., Y. Vugmeyster, A. Brunmark, H.L. Ploegh, and H.N. Eisen. 1998. Peptide antagonism and T cell receptor interactions with peptide-MHO complexes. Immunol. 9:475-483.
44. Lyons, D.S., S.A. Lieberman, J. Hampl, J.J. Boniface, Y. Chien, L.J. Berg, and M.M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 5:53-61.
45. Wheeler, C.J., P. von Hoegen, and J.R. Parnes. 1992. An immunological role for the CD8 beta-chain. Nature. 357: 247-249.
46. Renard, V., P. Romero, E. Vivier, B. Malissen, and I.F. Luescher. 1996. CD8β increases CD8 coreceptor function and participation in TCR-ligand binding. J. Exp. Med. 184:2439-2444.
47. Nakayama, K., I. Negishi, K. Kuida, M.C. Louie, O. Kanagawa, H. Nakauchi, and D.Y. Loh. 1994. Requirement for CD8β chain in positive selection of CD8-lineage T cells. Science. 263:1131-1133.
48. Crooks, M.E., and D.R. Littman. 1994. Disruption of T lymphocyte positive and negative selection in mice lacking the CD8β chain. Immunity. 1:277-285.
49. Itano, A., D. Cado, F.K. Chan, and E. Robey. 1994. A role for the cytoplasmic tail of the beta chain of CD8 in thymic selection. Immunity. 1:287-290.
50. Zamoyska, R. 1994. The CD8 coreceptor revisited: one chain good, two chains better. Immunity. 1:243-246.
51. Eichmann, K., A. Ehrfeld, I. Falk, H. Goebel, J. Kupsch, A. Reimann, A. Zgaga-Griesz, K.M. Saizawa, P. Yachelini, and K. Tomonari. 1991. Affinity enhancement and transmembrane signaling are associated with distinct epitopes on the CD8 alpha beta heterodimer. J. Immunol. 147:2075-2081.
52. Kwan Lim, G.E., L. McNeill, K. Whitley, D.L. Becker, and R. Zamoyska. 1998. Co-capping studies reveal CD8/TCR interactions after capping CD8 beta polypeptides and intracellular associations of CD8 with p56(lck). Eur. J. Immunol. 28:745-754.
53. Busch, D.H., and E.G. Pamer. 1999. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189:701-710.